← Back to all stories

The US Leads The World In The Weight-Loss Injection Boom

The US Leads The World In The Weight-Loss Injection Boom Novo Nordisk’s obesity-drug franchise has surged at a remarkable pace. In just four years, revenue from its weight-management treatments ballooned roughly tenfold - from about $1.3 billion in 2021 to approximately $12.4 billion in 2025. The growth has been fueled…
Zerohedge • 17 hours ago

Share this story:

LinkedIn Reddit
Read full article at Zerohedge →

►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None